Dr. Simonson held biological development and research leadership roles at Salsbury Laboratories, Solvay, Oxford Laboratories, and The Upjohn Company, and licensed the original swine biologics line for Oxford Laboratories.
Dr. Freese has practiced veterinary medicine for more than 40 years in Southwest Minnesota. He co-founded both Oxford Laboratories (now owned by Merck) and Newport Laboratories (now owned by Merial).
Jon has over 20 years of experience in animal health biologics and has held management positions in production, R&D, technical transfer, and regulatory affairs. Jon led development of the first and only USDA-licensed modified live Haemophilus parasuis vaccine.
From Clostridium perfringens Type A to Influenza D, autogenous vaccines offer veterinarians a targeted response to disease challenges, customized to individual needs in a timely manner.
Eric has over 15 years of experience in the animal health industry. He was a research scientist at Newport Laboratories and spent five years at Camas Inc., which manufactured chicken antibody-based feed additives for cattle and pigs.
Cambridge Technologies provides veterinarians with diagnostics, manufacturing, and service to help manage existing and emerging animal health problems.
